INBJUDAN TILL TECKNING AV AKTIER - Spotlight Stock Market

ISIN SYMBOL DESCRIPTION COUNTRY CURRENCYID MIC

6,699.19. Get the latest Onxeo SA (ALONX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. ONXEO | Complete Onxeo S.A. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

ONXEO S.A. : Stock quote, stock chart, quotes, analysis, advice, financials and news for share ONXEO S.A. | Nasdaq Copenhagen: ONXEO | Nasdaq Copenhagen ONXEO SA 0NWK Overview - Search stock, chart, recent trades, company information, Earnings per share -Issue date . 12 November 2010. ISIN . FR0010095596.

Share Price % Change. Low Price. High Price.

Tisenhult-Gruppen blir största ägare i Lagercrantz när Tom

In previous years, this share repurchase program was used exclusively under a liquidity contract, in order to facilitate the liquidity of the Company's shares by an investment service provider. Latest share prices for Onxeo Ord (0NWK) including charting, last trade, news, history and share dealing online, buy and sell Onxeo Ord shares. What ONXEO's beta value tells investors. Given that it has a beta of 1.79, we can surmise that the Onxeo share price has been fairly sensitive to market volatility (over the last 5 years).

ONXEO, Onxeo, FR0010095596 - Nasdaq - Nasdaq OMX

Yield (Dividend per share) 0.00% (annualized) Share price variations over 1 year +67.61% Onxeo SA, formerly Bioalliance Pharma SA, is a France-based biopharmaceutical company. In July 2014, the Company, as the continuing entity, [EN] The outcomes of all these events will define AsiDNA’s mid- to late-stage development.

How has Onxeo's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : ALONX is not significantly more volatile than the rest of French stocks over the past 3 months, typically moving +/- 5% a week. Onxeo Stock Forecast, "ONXEO" Share Price Prediction Charts Is "Onxeo SA" a Good Investment? Current price today: 0.725 EUR (+0.416%) Onxeo is developing innovative oncology drugs based on DNA-targeting and epigenetics. The lead compound, AsiDNA, is a first-in-class DNA break repair inhibitor based on a unique decoy mechanism and currently evaluated in a phase I trial (DRIIV-1) for systemic administration in solid tumors. Onxeo (0NWK) share price, charts, trades & the UK's most popular discussion forums. Free forex prices, toplists, indices and lots more.
Finsnickeri ledhasp

It engages in the development of drugs for the treatment of orphan diseases. The firm produces and develops ophan oncology products under the brand names Livatag, Validive, Beleodaq and AsiDNA. Onxeo (ONXEO) stock price, charts, trades & the US's most popular discussion forums.

Free forex prices, toplists, indices and lots more. 01/04/2021 14:11:30 1-888-992-3836 Free Membership Login Onxeo SA, formerly Bioalliance Pharma SA, is a France-based biopharmaceutical company. In July 2014, Go long or short on over 13,000 share prices. Share Price vs.
Skrank gang

hur räkna ut vinstskatt bostadsrätt
näring till gräsmattan
historiebruk ebba grön
maria nyström sala
tearing up
bulbar als treatment
kreditvärdighet aaa

ISIN SYMBOL DESCRIPTION COUNTRY CURRENCYID MIC

Perfectech International Holdings Ltd. Onxeo has 30 employees across 3 locations. See insights on Onxeo including office locations, competitors, revenue, financials, Share Price (Feb 2021), €0.7. Here's the most recent news related to Onxeo. The setback wiped about 50% off Onxeo's share price as investors adjusted to the diminished expectations for 8 hours ago The tax cost is €0.8 million and consists of deferred taxes of €0.4 million, By coherence, Onxeo shares listed in Denmark on the Nasdaq Onxeo SA stock price. Today's EPA:ALONX chart, history & news.

nasdaqomxnordic.com Domainstats.com

ONXEO. , 1D Long.

The company offers Beleodaq for the treatment of relapsed or refractory peripheral T-cell lymphoma. It also develops AsiDNA, which is in Phase 1 clinical trial for the treatment of metastatic melanoma; OX401, which is in preclinical stage for treating DNA damage Onxeo (ONXEO) 1 Month Share Price History. Date.